Assembly of the production line in Brazil will start in November 2024 and will replicate the technical model implemented in South Dakota, USA.
“Brazil provides a significant opportunity for our expansion, given the vast area of more than 96 million hectares of arable land and the continued growth of the market for specialty plant nutrition and microorganism products (…),” Vlad Popescu, Norofert’s chairman of the board, says.
“The partnership with Engenutri Group, renowned for its expertise in bacteria-based products, will allow us to bring Norofert’s technology to Brazil, replicating the successful model implemented in the US. In the first phase, we will license 16 Norofert branded products for this new market.”
The project to enter the Brazilian market commenced in August 2023 and Norofert Brasil LTDA was established this year. The new entity is owned 50% by Norofert S.A. and 50% by the Engenutri Group, which has revenue of EUR30 million and is part of the PH2 Participacoes holding company.
Norofert Brasil LTDA will start construction of the plant in November and work is expected to be completed in about two months.
(English version by Loredana Fratila-Cristescu)